Potential biomarker for early risk assessment of prostate cancer

Prostate

Volumn 66, Issue 14, 2006, Pages 1565-1571

  Markushin, Y ^a   Gaikwad, N ^b   Zhang, H ^c   Kapke, P ^c   Rogan, E G ^b   Cavalieri, E L ^b   Trock, B J ^d   Pavlovich, C ^d   Jankowiak, R ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c IOWA STATE UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; DNA adducts; Estrogens; Prostate cancer; Risk assessment

Indexed keywords

4 HYDROXYESTRADIOL; 4 HYDROXYTESTOSTERONE; DNA; MONOCLONAL ANTIBODY; TUMOR MARKER;

ABSORPTION SPECTROSCOPY; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA ADDUCT; EARLY DIAGNOSIS; HUMAN; LUMINESCENCE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; URINALYSIS;

ANTIBODIES, MONOCLONAL; DNA ADDUCTS; EARLY DIAGNOSIS; ELECTROPHORESIS, CAPILLARY; ESTRADIOL; HUMANS; HYDROXYESTRONES; MALE; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 33749054059     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20484     Document Type: Article

References (25)

1. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, Rogan EG. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997;94(20):10937-10942.
2. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 2000;21(1):40-54.
3. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J Natl Cancer Inst Monogr 2000;27:75-93.
4. Rogan EG, Badawi AF, Devanesan PD, Meza JL, Edney JA, West WW, Higginbotham SM, Cavalieri EL. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: Potential biomarkers of susceptibility to cancer. Carcinogenesis 2003;24(4):697-702.
5. Cavalieri EL, Rogan E, Chakravarti D. The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases. In: Sies H, Packer L, editors. Methods in Enzymology, Quinones and Quinone Enzymes, Part B. Duesseldorf, Germany: Elsevier; 2004. p 293.
6. Li KM, Todorovic R, Devanesan P, Higginbotham S, Kofeler H, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 2004;25(2):289-297.
7. Zahid M, Kohli E, Saeed M, Rogan E, Cavalieri E. The greater reactivity of estradiol-3,4-quinone vs. estradiol-2,3-quinone with DNA in the formation of depurinating adducts: Implications for tumor-initiating activity. Chem Res Toxicol 2006;19(1):164-172.
8. Chakravarti D, Mailander PC, Li KM, Higginbotham S, Zhang HL, Gross ML, Meza JL, Cavalieri EL, Rogan EG. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 2001;20(55):7945-7953.
9. Chakravarti D, Mailander PC, Higginbotham S, Cavalieri EL, Rogan EG. The catechol estrogen-3,4-quinone metabolite induces mutations in the mammary gland of ACI rats. Proc Amer Assoc Cancer Res 2003;44:180.
10. Guttenplan JB. Effects of estradiol, 4-hydroxyestradiol and estradiol 2,3- and 3,4-quinones on mutagenesis in vivo and in vitro. U.S. Army Breast Cancer Research Program Era of Hope meeting, June 8-11, 2005.
11. Zhao Z, Kosinska W, Khmelnitsky M, Cavalieri EL, Rogan EG, Chakravarti D, Sacks PG, Guttenplan JB. Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB Rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol. Chem Res Toxicol 2006;19(3):475-479.
12. Russo J, Hasan Lareef M, Balogh G, Guo S, Russo IH. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 2003;87(1):1-25.
13. Lareef MH, Garber J, Russo PA, Russo IH, Heulings R, Russo J. The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol 2005; 26(2):423-429.
14. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-616.
15. Bosland MC. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 2000;27:39-66.
16. Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 1986;76(1):45-48.
17. Leav I, Merk FB, Kwan PW, Ho SM. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 1989;15(1):23-40.
18. Bosland MC, Ford H, Horton L. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17β or diethylstilbestrol. Carcionogenesis 1995;16(6):1311-1317.
19. Markushin Y, Zhong W, Cavalieri EL, Rogan EG, Small GJ, Yeung ES, Jankowiak R. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Chem Res Toxicol 2003;16(9):1107-1117.
20. Dwivedy I, Devanesan P, Cremonesi P, Rogan E, Cavalieri E. Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens. Chem Res Toxicol 1992;5(6):828-833.
21. Stack DE, Byun J, Gross ML, Rogan EG, Cavalieri EL. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem Res Toxicol 1996;9(5):851-859.
22. Antibodies: A Laboratory Manual, Chapter 6: Monoclonal Antibodies. Harlow E, Lane D, editors. Plainview, NY: Cold Spring Habor; 1988, pp 139-243.
23. Markushin Y, Kapke P, Saeed M, Zhang H, Dawoud A, Rogan EG, Cavalieri EL, Jankowiak R. Development of monoclonal antibodies to 4-hydroxyestrogen-2-N- Acetylcysteine conjugates: Immunoaffinity and spectroscopic studies. Chem Res Toxicol 2005;18(10):1520-1527.
24. Jankowiak R, Markushin Y, Cavalieri EL, Small GJ. Spectroscopic characterization of the 4-hydroxy catechol estrogen quinones-derived GSH and N-acetylated Cys conjugates. Chem Res Toxicol 2003;16(3):304-311.
25. Quirino JP, Terabe S. Sample stacking of cationic and anionic analytes in capillary electrophoresis. J Chromatogr A 2000;902(1):119-135.